New patent for Strongbridge drug RECORLEV

Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. It is available from one supplier. There are seven patents protecting…

The post New patent for Strongbridge drug RECORLEV appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog